An article about antisense oligonucleotides was recently published in the New England Journal of Medicine. While this new medication provides an 80% reduction of Lp (a) or lipoprotein(a), it appears to be not yet ready for primetime. Lp(a) is a variation of LDL, and some known ways to decrease it include statins, niacin, apheresis, and L-carnitine.

Lp(a)- the new antisense drugs - the NEJM article

PrevMed Health, founded by Dr. Ford Brewer, MD, MPH, board certified in preventive and occupational medicine, focuses on preventing heart attacks,strokes, type 2 Diabetes, cognitive decline, and other chronic diseases. We are your Prev Med Health team, here to reduce or eliminate risks through education, attentive care, state-of-the-art genetic testing, imaging, lab tests, and telemedicine options.

Share Lp(a)- the new antisense drugs - the NEJM article

Sign up to save your podcasts

Lp(a)- the new antisense drugs - the NEJM article

Lp(a)- the new antisense drugs - the NEJM article

More shows like Dr Ford Brewer - PrevMed

The Jesse Chappus Show

Heart Doc VIP with Dr. Joel Kahn

Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast

Dhru Purohit Show

The Dr. Gundry Podcast

Low Carb MD Podcast

Metabolic Freedom With Ben Azadi

Dr. Shawn Baker Podcast

Dr. Jockers Functional Nutrition

The Metabolic Classroom with Dr. Ben Bikman

Stay Off My Operating Table

Keto Made Simple - Learn With Doctor Westman

Keto/Carnivore Conversations

The Metabolic Link

The Primal Podcast